Holen Sie sich die Stockscreener-App
2.06
6.79%
-0.15
Vorhandelsmarkt:
2.14
0.08
+3.88%
Schlusskurs vom Vortag:
$2.21
Offen:
$2.25
24-Stunden-Volumen:
603.78K
Relative Volume:
0.40
Marktkapitalisierung:
$161.44M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.57%
1M Leistung:
-60.31%
6M Leistung:
+71.52%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.06
$2.31
1-Wochen-Bereich:
$1.75
$2.37
52-Wochen-Spanne:
$0.5506
$6.19
Citius Oncology Inc Stock (CTOR) Company Profile
Firmenname
Citius Oncology Inc
Sektor
Telefon
(908) 967-6677
Adresse
11 COMMERCE DRIVE, CRANFORD
Vergleichen Sie CTOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTOR
Citius Oncology Inc
|
2.06 | 173.20M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
147.38 | 64.91B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.16 | 43.33B | 29.98B | 958.27M | 5.31B | 0.2964 |
|
HLN
Haleon Plc Adr
|
9.66 | 42.36B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.38 | 17.72B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
294.28 | 12.42B | 2.99B | 1.21B | 1.13B | 25.06 |
Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-27 | Eingeleitet | Maxim Group | Buy |
Citius Oncology Inc Aktie (CTOR) Neueste Nachrichten
What analysts say about Citius Oncology Inc. stockMaximize gains with proven stock analysis - jammulinksnews.com
What institutional investors are buying Citius Oncology Inc. stockInvest smarter with expert stock recommendations - jammulinksnews.com
What is the risk reward ratio of investing in Citius Oncology Inc. stockUnlock exclusive trading strategies for gains - jammulinksnews.com
How volatile is Citius Oncology Inc. stock compared to the marketGet professional advice for portfolio optimization - jammulinksnews.com
Does Citius Oncology Inc. stock perform well during market downturnsUnlock real-time stock alerts for quick profits - jammulinksnews.com
How strong is Citius Oncology Inc. company’s balance sheetSkyrocketing returns - jammulinksnews.com
What are the latest earnings results for Citius Oncology Inc.Free Stock Market Trend Analysis - jammulinksnews.com
Why is Citius Oncology Inc. stock attracting strong analyst attentionAchieve breakthrough investment performance - jammulinksnews.com
What is Citius Oncology Inc. company’s growth strategyBuild a portfolio for long-term financial success - jammulinksnews.com
Should I hold or sell Citius Oncology Inc. stock in 2025Capitalize on market trends early - jammulinksnews.com
What drives Citius Oncology Inc. stock priceGet timely market insights for better trades - jammulinksnews.com
What are analysts’ price targets for Citius Oncology Inc. in the next 12 monthsFree Daily Trading Room Entry - jammulinksnews.com
How does Citius Oncology Inc. compare to its industry peersBreakthrough stock performance - jammulinksnews.com
How does Citius Oncology Inc. generate profit in a changing economyPost Market Target Finder To Watch Now - jammulinksnews.com
What makes Citius Oncology Inc. stock attractive to long term investorsPortfolio Diversification Stock Ideas From Experts - metal.it
Published on: 2025-07-29 19:38:23 - metal.it
Trendline Breach Raises Concern for Citius Oncology Inc. InvestorsFundamental + Technical Hybrid Stock Tips Shared - metal.it
Citius Oncology Inc. Stock Support and Resistance Levels You Should KnowVerified Return Tips - metal.it
Is Citius Oncology Inc. a good long term investmentExceptional trading performance - Autocar Professional
Citius Oncology Announces Closing of $9.0 Million Public Offering - StreetInsider
Citius Oncology Inc. Stock Analysis and ForecastMarket-leading capital gains - Autocar Professional
Citius Oncology shares surge 50.91% intraday after signing LYMPHIR distribution agreement with Cencora. - AInvest
Finanzdaten der Citius Oncology Inc-Aktie (CTOR)
Es liegen keine Finanzdaten für Citius Oncology Inc (CTOR) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.87%
0.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):